Modulation of gut microbiota through in vitro exposure to a traditional fermented food in the context of pathogen invasion
Nyati, M.; van Mastrigt, O.; Talsma, E. F.; Shindano, J.; ZWAAN, B.; Schoustra, S.
Show abstract
The gut microbiota consisting of bacteria, fungi, archea, and viruses and plays a role as a barrier against pathogen invasion to promote intestinal health and preventing organismal infections. This study examined the potential protective properties of Mabisi, a widely consumed traditional fermented dairy product in Zambia, against pathogen invasion in the gut. Using the in-vitro static INFOGEST model, we challenged the gut microbiota from a pooled stool sample pf six Zambian children) and previously exposed to Mabisi by adding model pathogens. We hypothesized that pathogen invasion is suppressed in in-vitro gut microbiota treated with Mabisi due to its ability to modulate the gut microbiota composition. Our microbiota challenge treatments were Mabisi, fructooligosaccharides (FOS) as a positive control, sterile water as a negative control, and with and without pathogens. Out of the two strains of pathogens added to the gut microbiota, Escherichia coli established in FOS treated gut microbiota, however not in Mabisi and sterile water treatments. Furthermore, we show that Mabisi modulated gut microbiota by increasing Pediococcus, a commensal bacteria and increased production of short chain fatty acids including acetate, propionate, lactate, isobutyrate, formate, and succinate in Mabisi treated gut microbiota compared to both FOS and sterile water treated gut microbiota. This study contributes to evidence of the beneficial role of fermented foods such as Mabisi through the prevention of pathogen invasion of the gut microbiota in children. ImportanceThis study provides evidence supporting the protective role of Mabisi, a traditional fermented dairy product, in preventing pathogen invasion in the gut microbiota of children. By using an in-vitro approach, we demonstrate that Mabisi treatment suppresses the establishment of Escherichia coli, a key pathogen, unlike fructooligosaccharides (FOS), a well-known prebiotic. Additionally, Mabisi modulates gut microbiota composition by increasing beneficial bacteria such as Pediococcus and enhancing short-chain fatty acid (SCFA) production, which is essential for gut health. These findings highlight the potential of traditional fermented foods as affordable, accessible dietary interventions for improving gut health and preventing infections, particularly in low-resource settings like Zambia.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism 95%
- Deprivation of dietary fiber in specific-pathogen-free mice promotes susceptibility to the intestinal mucosal pathogen Citrobacter rodentium 95%
- Fusobacterium sphaericum sp. nov., isolated from a human colon tumor, adheres to colonic epithelial cells and induces IL-8 secretion 94%
Similar papers in this journal
- New insights into the cultivability of human milk microbiota from ingestion to digestion and implications for its immunomodulatory properties 96%
- First evidence of production of the lantibiotic nisin P 95%
- Using fecal immunochemical tubes for the analysis of gut microbiome has potential to improve colorectal cancer screening 94%
Similar papers in this journal
- Dietary fat promotes antibiotic-induced Clostridioides difficile mortality in mice 95%
- Impact of the RaS-RiPP tryglysin and culturing conditions on ex-vivo oral microbiomes. 95%
- Clinically Relevant Pathogens on Surfaces Display Differences in Survival and Transcriptomic Response in Relation to Probiotic and Traditional Cleaning Strategies 95%
Similar papers in this journal
- Defining the resilience of the human salivary microbiota by a 520 days longitudinal study in confined environment: the Mars500 mission 93%
- CViewer: A Java-based statistical framework for integration of shotgun metagenomics with other omics datasets 93%
- Sulfoquinovose is differently degraded by the mouse and human gut microbiota and not metabolized by the host 93%
Similar papers in this journal
- Impact of time and temperature on gut microbiota and SCFA composition in stool samples 95%
- Longitudinal impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice 94%
- Dietary cystine restriction increases the proliferative capacity of the small intestine of mice 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.